DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Italy
  • /
  • Materials
Author Program NEWCreate Narrative
SOL logo

SOL S.p.A. Stock Price

BIT:SOL Community·€5.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

SOL Share Price Performance

€54.90
2.20 (4.17%)
​
€54.90
2.20 (4.17%)
​
Price €54.90
Sun, 20 Sep 26
Share Pricen/a

SOL Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with adequate balance sheet.

1 Risk
2 Rewards
View Full Analysis

SOL S.p.A. Key Details

€1.9b

Revenue

€1.4b

Cost of Revenue

€492.4m

Gross Profit

€319.1m

Other Expenses

€173.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
1.91
26.24%
9.24%
71.0%
View Full Analysis

About SOL

Founded
1927
Employees
8000
CEO
Aldo Romario
WebsiteView website
www.solgroup.com

SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally. The company supplies technical gases, equipment, systems, and services for the industrial sectors; and produces and distributes gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous helium, liquid helium, gases for electronics, ammonia, combustible gases for industrial use, and liquefied natural gas. It also provides medical gases with AIC and medical devices, training services, electromedical equipment services, hospital hygiene and environmental monitoring, ambulance management, design and development of biobanks, and InfoHealth solutions; and respiratory and infusion therapies, healthcare and social care services, telemedicine and digital services, and healthcare aids. In addition, the company offers CRYOLAB for transfer, storage and handling services of biological samples; DIATHEVA, which focuses on research, development, production, and marketing products, including monoclonal antibodies, recombinant proteins, and molecular kits for hospital research, diagnosis and clinical application, environmental, veterinary, and food; and PERSONAL GENOMICS for preventive and precision medicine. SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Gas And Technologies World B.V.

Recent SOL News & Updates

Recent updates

No updates

SOL S.p.A. Competitors

BZU logo

Buzzi

Symbol: BIT:BZU
Market cap: €6.6b
CEM logo

Cementir Holding

Symbol: BIT:CEM
Market cap: €2.1b
CALT logo

Caltagirone

Symbol: BIT:CALT
Market cap: €1.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide